retatrutide clinical trials update Tirzepatide vs. Retatrutide UK: Clinical Progress, Expected
Description
When you start GLP-1 therapy and your glucose control improves, we sometimes see changes in your retinal blood vessels
The most common time to experience side effects is when you first start taking a GLP-1 or when there is a prescribed increase in your dose
However, a BMI in the obese range has been associated with low-grade inflammation, which could cause worse outcomes
Check with your HR department you may have coverage even if standard Kaiser plans don't include it
